FDA Releases Guidances on Transition Plan for Devices Distributed Under Emergency Use Authorization (EUA) or Enforcement Policies During COVID-19

January 12, 2022

FDA Releases Guidance for Digital Health Tech Used in Clinical Investigations

January 6, 2022

FDA Proposes Risk-Based and Remote Inspection Strategies in New Report

May 7, 2021

Breaking Down FDA’s New Remote Monitoring Strategy

April 15, 2021

FDA Announces Facility Fees for OTC Drug Manufacturers

March 29, 2021

FDA Update: The Latest on Vaccine Development, Inspections, and Conducting Clinical Trials During Covid-19

September 25, 2020

FDA Announces Plans to Resume Domestic On-site Inspections

July 16, 2020

FDA Issue Guidance on Manufacturing Drugs, APIs during COVID-19

June 25, 2020

Navigating FDA Policies for PPE, and Liability Protections

June 12, 2020

Going Virtual: Clinical Trials, Telemedicine, Electronic Medical Records, And All That.

June 8, 2020

FDA Updates Policy to Curb Unreliable COVID-19 Antibody Tests

May 6, 2020

Upping Hospitals’ Liability Defenses For COVID Measures

April 14, 2020

April 16 Update: Key FDA Actions for COVID-19 Devices and Therapies

April 14, 2020

Update: Key FDA Actions for COVID-19 Devices and Therapies

April 8, 2020

Personal Protective Equipment & Ventilators: How FDA Is Increasing Supply for the US Healthcare System

March 31, 2020